Cita APA

Alonso, E., Vale González, M. d. C., Rodríguez Vieytes, M., Laferla, F. M., Giménez-Llort, L., & Botana López, L. M. (2011). The cholinergic antagonist gymnodimine improves Aβ and tau neuropathology in an in vitro model of Alzheimer disease.

Citación estilo Chicago

Alonso, Eva, María del Carmen Vale González, Mercedes Rodríguez Vieytes, Frank M. Laferla, Lydia Giménez-Llort, y Luis Miguel Botana López. The Cholinergic Antagonist Gymnodimine Improves Aβ and Tau Neuropathology in an in Vitro Model of Alzheimer Disease. 2011.

Cita MLA

Alonso, Eva, et al. The Cholinergic Antagonist Gymnodimine Improves Aβ and Tau Neuropathology in an in Vitro Model of Alzheimer Disease. 2011.